Malta - English - Medicines Authority

astrazeneca ab se-151 85, södertälje, sweden - rosuvastatin - film-coated tablet - rosuvastatin 20 mg - lipid modifying agents

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - rosuvastatin - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; rosuvastatin

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - rosuvastatin calcium - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; rosuvastatin

Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - rosuvastatin - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; rosuvastatin

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - rosuvastatin - film-coated tablet - 20 milligram(s) - rosuvastatin

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca ab - rosuvastatin - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; rosuvastatin

Ireland - English - HPRA (Health Products Regulatory Authority)

grunenthal pharma ltd - rosuvastatin - film-coated tablet - hmg coa reductase inhibitors; rosuvastatin

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - rosuvastatin calcium 20.8mg equivalent to rosuvastatin 20mg;   - film coated tablet - 20 mg - active: rosuvastatin calcium 20.8mg equivalent to rosuvastatin 20mg   excipient: calcium phosphate crospovidone hypromellose iron oxide red lactose monohydrate   magnesium stearate microcrystalline cellulose purified water titanium dioxide triacetin - crestor should be used as an adjunct to diet when the response to diet and exercise is inadequate. prevention of major cardiovascular events in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease, (see clinical efficacy) crestor is indicated to: reduce the risk of nonfatal myocardial infarction reduce the risk of nonfatal stroke reduce the risk of coronary artery revascularisation

Kenya - English - Pharmacy and Poisons Board

astrazeneca parklands alderley park macclesfield cheshire - rosuvastatin calcium - film-coated tablet - each tablet contains 20 mg rosuvastatin (as… - plain lipid modifying agents: hmg coa reductase

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - rosuvastatin - coated tablets - 20mg milligram